Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Return on Equity (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Return on Equity for 10 consecutive years, with 0.87% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed N/A to 0.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.87% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.91% for FY2023, 16.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.87% at Crescent Biopharma, down from 0.4% in the prior quarter.
  • The five-year high for Return on Equity was 1.64% in Q1 2025, with the low at 3.47% in Q3 2024.
  • Average Return on Equity over 5 years is 0.83%, with a median of 0.81% recorded in 2023.
  • The sharpest move saw Return on Equity tumbled -272bps in 2024, then surged 307bps in 2025.
  • Over 5 years, Return on Equity stood at 0.71% in 2021, then plummeted by -44bps to 1.03% in 2022, then grew by 15bps to 0.87% in 2023, then tumbled by -299bps to 3.47% in 2024, then skyrocketed by 75bps to 0.87% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.87%, 0.4%, and 0.68% for Q4 2025, Q3 2025, and Q2 2025 respectively.